BRAF and cancer: Here, we have demonstrated a comprehensive characterization of a drug-resistant model including various mechanisms of resistance, such as upregulation of up- and downstream effectors of BRAF, acquisition of cancer stem-like traits, and elevated invasive and proteolytic activities.